{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:15:09Z","timestamp":1781702109078,"version":"3.54.5"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Collagenase injection is a relatively new, minimally invasive treatment option for Dupuytren disease. Most literature focusses on quantitative outcome measures, such as degree of residual contracture and recurrence. The patient experience of the treatment has rarely been explored. This study sought to explore patients\u2019 experiences of the treatment process, including their reasons for seeking and choosing the treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A qualitative descriptive design was used to explore patients\u2019 experiences. Seven patients (aged 57 to 81 years) who had received collagenase treatment for Dupuytren disease engaged in individual, semistructured interviews. Interviews were audio recorded, transcribed verbatim, and analyzed thematically.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Thematic analysis revealed that Dupuytren disease was an obstacle to doing things, but not a barrier. Patients \u201cwent with the flow\u201d of treatment, often taking a passive approach to their health care decisions. Patients found the collagenase injections to be extremely painful, but worth it. They had a varied knowledge of the disease and treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Patients were pleased with the results of the collagenase treatment, even if the finger was not completely straight or there was recurrence. The quick recovery and minimal complications were positive factors; however, the injections were extremely painful and could deter patients from future treatment. This research highlighted that a number of patients had low health literacy regarding their condition, and this affected their expectations of treatment outcomes and future treatment seeking. There are opportunities for health professionals to improve health literacy for people with Dupuytren disease, possibly in a group setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000008959","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T09:19:33Z","timestamp":1644916773000},"page":"913-917","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["\u201cExtremely Painful, but Worth It\u201d: The Lived Experience of Receiving Collagenase as Treatment for Dupuytren Disease"],"prefix":"10.1097","volume":"149","author":[{"given":"Matthew L.","family":"Molineux","sequence":"first","affiliation":[{"name":"From the Discipline of Occupational Therapy, School of Health Science and Social Work, Griffith University; and Occupational Therapy Department, Queen Elizabeth II Jubilee Hospital, Metro South Hospital and Health Service."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine","family":"McCann","sequence":"additional","affiliation":[{"name":"From the Discipline of Occupational Therapy, School of Health Science and Social Work, Griffith University; and Occupational Therapy Department, Queen Elizabeth II Jubilee Hospital, Metro South Hospital and Health Service."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth J.","family":"Cox","sequence":"additional","affiliation":[{"name":"From the Discipline of Occupational Therapy, School of Health Science and Social Work, Griffith University; and Occupational Therapy Department, Queen Elizabeth II Jubilee Hospital, Metro South Hospital and Health Service."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Cross","sequence":"additional","affiliation":[{"name":"From the Discipline of Occupational Therapy, School of Health Science and Social Work, Griffith University; and Occupational Therapy Department, Queen Elizabeth II Jubilee Hospital, Metro South Hospital and Health Service."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease.","volume":"6","author":"Shih","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/2000656X.2016.1159568","article-title":"Collagenase clostridium histolyticum: Emerging practice patterns and treatment advances.","volume":"50","author":"Warwick","year":"2016","journal-title":"J Plast Surg Hand Surg"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year data.","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R4-20250501","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jhsa.2016.07.090","article-title":"The impact of collagenase clostridium histolyticum introduction on Dupuytren treatment patterns in the United States.","volume":"41","author":"Zhao","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R5-20250501","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture.","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12891-019-2712-z","article-title":"Hand therapy or not following collagenase treatment for Dupuytren\u2019s contracture? Protocol for a randomised controlled trial.","volume":"20","author":"Aglen","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/bmb\/ldw032","article-title":"Collagenase clostridium histolyticum in Dupuytren\u2019s contracture: A systematic review.","volume":"118","author":"Smeraglia","year":"2016","journal-title":"Br Med Bull"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jhsa.2013.03.036","article-title":"The impact of Dupuytren disease on patient activity and quality of life.","volume":"38","author":"Wilburn","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1365-2702.2008.02692.x","article-title":"The lived experience of Dupuytren\u2019s disease of the hand.","volume":"18","author":"Pratt","year":"2009","journal-title":"J Clin Nurs"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jht.2008.08.003","article-title":"Evaluation of activity limitation and digital extension in Dupuytren\u2019s contracture three months after fasciectomy and hand therapy interventions.","volume":"22","author":"Engstrand","year":"2009","journal-title":"J Hand Ther"},{"key":"R11-20250501","first-page":"31","article-title":"Psychologic aspects of Dupuytren\u2019s disease: A new scale of subjective well-being of patients.","volume":"57","author":"Trybus","year":"2011","journal-title":"Ann Acad Med Stetin"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11552-014-9645-7","article-title":"Postapproval clinical experience in the treatment of Dupuytren\u2019s contracture with collagenase clostridium histolyticum (CCH): The first 1,000 days.","volume":"9","author":"Schulze","year":"2014","journal-title":"Hand"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ijcp.12099","article-title":"Dupuytren\u2019s disease presentation, referral pathways and resource utilisation in Europe: Regional analysis of a surgeon survey and patient chart review.","volume":"67","author":"Dahlin","year":"2013","journal-title":"Int J Clin Pract"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology.","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"R17-20250501","doi-asserted-by":"crossref","first-page":"1\u201313","DOI":"10.1177\/1609406917733847","article-title":"Thematic analysis: Striving to meet the trustworthiness criteria","volume":"16","author":"Nowell","year":"2017","journal-title":"Int J Qual Meth"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-Year data.","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bjps.2018.03.016","article-title":"Anesthesia for collagenase clostridium histolyticum injection in patients with Dupuytren disease: A cohort analysis.","volume":"71","author":"Sanjuan-Cerver\u00f3","year":"2018","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jhsa.2016.03.003","article-title":"Patient satisfaction with collagenase.","volume":"41","author":"Bradley","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R21-20250501","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/PRS.0000000000003583","article-title":"Benefit of local anesthesia in reducing pain during collagenase injection for Dupuytren\u2019s contracture.","volume":"140","author":"Nordenskj\u00f6ld","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"350e","DOI":"10.1097\/PRS.0000000000005209","article-title":"Universal measures of support are needed: A cross-sectional study of health literacy in patients with Dupuytren\u2019s disease.","volume":"143","author":"Roy","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R23-20250501","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/09638288.2017.1402095","article-title":"Patients\u2019 needs during a surgical intervention process for Dupuytren\u2019s disease.","volume":"41","author":"Turesson","year":"2019","journal-title":"Disabil Rehabil"},{"key":"R24-20250501","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/PRS.0000000000001878","article-title":"Patients\u2019 preferences for treatment for Dupuytren\u2019s disease: A discrete choice experiment.","volume":"137","author":"Kan","year":"2016","journal-title":"Plast Reconstr Surg"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:05:18Z","timestamp":1746140718000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000008959","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}